BDBM381831 US10272087, Compound 3

SMILES COc1cc(OC)cc(c1)N(CCO)c1ncc2ncc(nc2n1)-c1cnn(C)c1

InChI Key InChIKey=QANHPRIWWFSGTM-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 381831   

TargetFibroblast growth factor receptor 1(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381831(US10272087, Compound 3)
Affinity DataIC50: 79.4nMAssay Description:In a final reaction volume of 30 μL, FGFR1 (h) (25 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381831(US10272087, Compound 3)
Affinity DataIC50: 31.6nMAssay Description:In a final reaction volume of 30 μL, FGFR2 (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Tri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 3(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381831(US10272087, Compound 3)
Affinity DataIC50: 25.1nMAssay Description:In a final reaction volume of 30 μL, FGFR3 (h) (40 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 4(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381831(US10272087, Compound 3)
Affinity DataIC50: 100nMAssay Description:In a final reaction volume of 30 μL, FGFR4 (h) (60 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381831(US10272087, Compound 3)
Affinity DataIC50: 1.00E+3nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2020
Entry Details
Go to US Patent